跳至主要内容
临床试验/ACTRN12621000513819
ACTRN12621000513819已完成未知

Influence of Enzyme Rich Malt Extract on gut health symptoms of irritable bowel syndrome in adults

Edith Cowan University0 个研究点目标入组 49 人开始时间: 2021年5月3日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
49

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • Male and female participants will be between 18 - 65 years old and have been clinically diagnosed with IBS, meeting the Rome IV edition diagnostic criteria

排除标准

  • Pregnancy or planning to become pregnant,
  • Breastfeeding,
  • Having a known diagnosis of other gastrointestinal illness (e.g. Inflammatory Bowel Disease, malabsorption of any macronutrients, bowel resection, coeliac disease),
  • Previous abdominal or gastrointestinal surgeries, severe mental health and sleep-related conditions (e.g. insomnia), renal or hepatic diseases, and major medical illness,
  • Current use of pharmaceutical agents that could modify or treat IBS (e.g. probiotics, antibiotics, eluxadoline, lubiprostone and linaclotide),
  • Other restrictive dietary patterns or therapies (e.g. gluten-free, low-carbohydrate, or high-protein diets, keto/Paleo-diet),
  • Taken antibiotics or prebiotics in the past 6 weeks,
  • Any other known disease, condition or habit that may interfere with completion of study.

研究者

相似试验